Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis (Breast Cancer Research and Treatment, (2018), 171, 3, (535-544), 10.1007/s10549-018-4867-y)

Jiayu Wang; Binghe Xu; Wenna Wang; Xiaoyu Zhai; Xuelian Chen

doi:10.1007/s10549-018-5047-9

Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis (Breast Cancer Research and Treatment, (2018), 171, 3, (535-544), 10.1007/s10549-018-4867-y)

Jiayu Wang
, Binghe Xu
, Wenna Wang
, Xiaoyu Zhai
, Xuelian Chen

Health Science Center

Chinese Academy of Medical Sciences

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

In the original publication of the article, the authors’ affiliation was published incorrectly. The corrected affiliation is given in this correction. The author also found few corrections in the article which are given below.

Original language	English
Pages (from-to)	487
Number of pages	1
Journal	Breast Cancer Research and Treatment
Volume	173
Issue number	2
DOIs	https://doi.org/10.1007/s10549-018-5047-9
State	Published - 30 Jan 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s10549-018-5047-9

Fingerprint

Dive into the research topics of 'Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis (Breast Cancer Research and Treatment, (2018), 171, 3, (535-544), 10.1007/s10549-018-4867-y)'. Together they form a unique fingerprint.

Cite this

Wang, J., Xu, B., Wang, W., Zhai, X., & Chen, X. (2019). Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis (Breast Cancer Research and Treatment, (2018), 171, 3, (535-544), 10.1007/s10549-018-4867-y). Breast Cancer Research and Treatment, 173(2), 487. https://doi.org/10.1007/s10549-018-5047-9

Wang, Jiayu ; Xu, Binghe ; Wang, Wenna et al. / Correction to : Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis (Breast Cancer Research and Treatment, (2018), 171, 3, (535-544), 10.1007/s10549-018-4867-y). In: Breast Cancer Research and Treatment. 2019 ; Vol. 173, No. 2. pp. 487.

@article{5472484a4d3a4be0972c0fa5a4a6eb25,

title = "Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis (Breast Cancer Research and Treatment, (2018), 171, 3, (535-544), 10.1007/s10549-018-4867-y)",

abstract = "In the original publication of the article, the authors{\textquoteright} affiliation was published incorrectly. The corrected affiliation is given in this correction. The author also found few corrections in the article which are given below.",

author = "Jiayu Wang and Binghe Xu and Wenna Wang and Xiaoyu Zhai and Xuelian Chen",

note = "Publisher Copyright: {\textcopyright} 2018, Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2019",

month = jan,

day = "30",

doi = "10.1007/s10549-018-5047-9",

language = "英语",

volume = "173",

pages = "487",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer",

number = "2",

}

Wang, J, Xu, B, Wang, W, Zhai, X & Chen, X 2019, 'Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis (Breast Cancer Research and Treatment, (2018), 171, 3, (535-544), 10.1007/s10549-018-4867-y)', Breast Cancer Research and Treatment, vol. 173, no. 2, pp. 487. https://doi.org/10.1007/s10549-018-5047-9

Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis (Breast Cancer Research and Treatment, (2018), 171, 3, (535-544), 10.1007/s10549-018-4867-y). / Wang, Jiayu; Xu, Binghe; Wang, Wenna et al.
In: Breast Cancer Research and Treatment, Vol. 173, No. 2, 30.01.2019, p. 487.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis (Breast Cancer Research and Treatment, (2018), 171, 3, (535-544), 10.1007/s10549-018-4867-y)

AU - Wang, Jiayu

AU - Xu, Binghe

AU - Wang, Wenna

AU - Zhai, Xiaoyu

AU - Chen, Xuelian

PY - 2019/1/30

Y1 - 2019/1/30

N2 - In the original publication of the article, the authors’ affiliation was published incorrectly. The corrected affiliation is given in this correction. The author also found few corrections in the article which are given below.

AB - In the original publication of the article, the authors’ affiliation was published incorrectly. The corrected affiliation is given in this correction. The author also found few corrections in the article which are given below.

UR - https://www.scopus.com/pages/publications/85057123104

U2 - 10.1007/s10549-018-5047-9

DO - 10.1007/s10549-018-5047-9

M3 - 评论/辩论

C2 - 30470975

AN - SCOPUS:85057123104

SN - 0167-6806

VL - 173

SP - 487

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 2

ER -

Wang J, Xu B, Wang W, Zhai X, Chen X. Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis (Breast Cancer Research and Treatment, (2018), 171, 3, (535-544), 10.1007/s10549-018-4867-y). Breast Cancer Research and Treatment. 2019 Jan 30;173(2):487. doi: 10.1007/s10549-018-5047-9

Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis (Breast Cancer Research and Treatment, (2018), 171, 3, (535-544), 10.1007/s10549-018-4867-y)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this